Article
Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
Scientific reports - 27 Apr 2024
Pitakkitnukun Palada, Pongpitakmetha Thanakit, Suttichet Thitima Benjachat, Sukkummee Warumphon, Chariyavilaskul Pajaree, Polprasert Chantana
Abstract excerpt
High-dose methotrexate (HD-MTX) is a widely used chemotherapy regimen for hematologic malignancies such as lymphomas and acute lymphoblastic leukemia, but its use can lead to adverse effects, including acute kidney injury (AKI), impaired liver function, and mucositis, causing extended hospital stays and delayed subsequent chemotherapy. Our study aimed to investigate the predictive factors for renal toxicities...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
